119-hr2483

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2483 Enrolled Bill

    (ENR) ]

 H.R.2483

 One Hundred Nineteenth Congress

 of the

 United States of America

 AT THE FIRST SESSION

 Begun and held at the City of Washington on Friday,
 the third day of January, two thousand and twenty-five

 An Act

 To reauthorize certain programs that provide for opioid use disorder 
 prevention, treatment, and recovery, and for other purposes.

 Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE; TABLE OF CONTENTS.

    (a) Short Title.--This Act may be cited as the ``SUPPORT for 
Patients and Communities Reauthorization Act of 2025''.

    (b) Table of Contents.--The table of contents for this Act is as 
follows:

Sec. 1. Short title; table of contents.

 TITLE I--PREVENTION

Sec. 101. Prenatal and postnatal health.

Sec. 102. Monitoring and education regarding infections associated with 
 illicit drug use and other risk factors.

Sec. 103. Preventing overdoses of controlled substances.

Sec. 104. Support for individuals and families impacted by fetal alcohol 
 spectrum disorder.

Sec. 105. Promoting state choice in PDMP systems.

Sec. 106. First responder training program.

Sec. 107. Donald J. Cohen National Child Traumatic Stress Initiative.

Sec. 108. Protecting suicide prevention lifeline from cybersecurity 
 incidents.

Sec. 109. Monitoring and reporting of child, youth, and adult trauma.

Sec. 110. Bruce's law.

Sec. 111. Guidance on at-home drug disposal systems.

Sec. 112. Assessment of opioid drugs and actions.

Sec. 113. Grant program for State and Tribal response to opioid use 
 disorders.

 TITLE II--TREATMENT

Sec. 201. Residential treatment program for pregnant and postpartum 
 women.

Sec. 202. Improving access to addiction medicine providers.

Sec. 203. Mental and behavioral health education and training grants.

Sec. 204. Loan repayment program for substance use disorder treatment 
 workforce.

Sec. 205. Development and dissemination of model training programs for 
 substance use disorder patient records.

Sec. 206. Task force on best practices for trauma-informed 
 identification, referral, and support.

Sec. 207. Grants to enhance access to substance use disorder treatment.

Sec. 208. State guidance related to individuals with serious mental 
 illness and children with serious emotional disturbance.

Sec. 209. Reviewing the scheduling of approved products containing a 
 combination of buprenorphine and naloxone.

Sec. 210. References to opioid overdose reversal agents in HHS grant 
 programs.

Sec. 211. Roundtable on using health information technology to improve 
 mental health and substance use care outcomes.

 TITLE III--RECOVERY

Sec. 301. Building communities of recovery.

Sec. 302. Peer support technical assistance center.

Sec. 303. Comprehensive opioid recovery centers.

Sec. 304. Youth prevention and recovery.

Sec. 305. CAREER Act.

Sec. 306. Addressing economic and workforce impacts of the opioid 
 crisis.

Sec. 307. Review of information related to funding opportunities under 
 programs administered by SAMHSA.

 TITLE IV--MISCELLANEOUS MATTERS

Sec. 401. Delivery of a controlled substance by a pharmacy to a 
 prescribing practitioner.

Sec. 402. Required training for prescribers of controlled substances.

 TITLE I--PREVENTION

 

SEC. 101. PRENATAL AND POSTNATAL HEALTH.
 

Section 317L
            (d) of the Public Health Service Act (42 U.S.C. 247b-
13
            (d) ) is amended by striking ``such sums as may be necessary for each 
of the fiscal years 2019 through 2023'' and inserting ``$4,250,000 for 
each of fiscal years 2026 through 2030''.
 

SEC. 102. MONITORING AND EDUCATION REGARDING INFECTIONS ASSOCIATED 
 WITH ILLICIT DRUG USE AND OTHER RISK FACTORS.
 

Section 317N
            (d) of the Public Health Service Act (42 U.S.C. 247b-
15
            (d) ) is amended by striking ``fiscal years 2019 through 2023'' and 
inserting ``fiscal years 2026 through 2030''.
 

SEC. 103. PREVENTING OVERDOSES OF CONTROLLED SUBSTANCES.

    (a) In General.--

Section 392A of the Public Health Service Act (42 
U.S.C. 280b-1) is amended--

    (1) in subsection

    (a)

    (2) --
        (A) in subparagraph
            (C) , by inserting ``and associated 
 risks'' before the period at the end; and
        (B) in subparagraph
            (D) , by striking ``opioids'' and 
 inserting ``substances causing overdose''; and

    (2) in subsection

    (b)

    (2) --
        (A) in subparagraph
        (B) , by inserting ``, and associated 
 risk factors,'' after ``such overdoses'';
        (B) in subparagraph
            (C) , by striking ``coding'' and 
 inserting ``monitoring and identifying'';
            (C) in subparagraph
        (E) --
            (i) by inserting a comma after ``public health 
 laboratories''; and
            (ii) by inserting ``and other emerging substances 
 related'' after ``analogues''; and
            (D) in subparagraph
        (F) , by inserting ``and associated risk 
 factors'' after ``overdoses''.

    (b) Additional Grants.--

Section 392A

    (a)

    (3) of the Public Health 
Service Act (42 U.S.C. 280b-1

    (a)

    (3) ) is amended--

    (1) in the matter preceding subparagraph
        (A) , by striking ``and 
 Indian Tribes--'' and inserting ``and Indian Tribes for the 
 following purposes:'';

    (2) by amending subparagraph
        (A) to read as follows:
 ``
        (A) To carry out innovative projects for grantees to 
 detect, identify, and rapidly respond to controlled substance 
 misuse, abuse, and overdoses, and associated risk factors, 
 including changes in patterns of such controlled substance use. 
 Such projects may include the use of innovative, evidence-based 
 strategies for detecting such patterns, such as wastewater 
 surveillance, if proven to support actionable prevention 
 strategies, in a manner consistent with applicable Federal and 
 State privacy laws.''; and

    (3) in subparagraph
        (B) , by striking ``for any'' and inserting 
 ``For any''.
            (c) Authorization of Appropriations.--

Section 392A

    (e) of the Public 
Health Service Act (42 U.S.C. 280b-1

    (e) ) is amended by striking 
``$496,000,000 for each of fiscal years 2019 through 2023'' and 
inserting ``$505,579,000 for each of fiscal years 2026 through 2030''.
 

SEC. 104. SUPPORT FOR INDIVIDUALS AND FAMILIES IMPACTED BY FETAL 
 ALCOHOL SPECTRUM DISORDER.

    (a) In General.--Part O of title III of the Public Health Service 
Act (42 U.S.C. 280f et seq.) is amended to read as follows:

 ``PART O--FETAL ALCOHOL SPECTRUM DISORDER PREVENTION AND SERVICES 
 PROGRAM

``

SEC. 399H. FETAL ALCOHOL SPECTRUM DISORDERS PREVENTION, INTERVENTION, 
AND SERVICES DELIVERY PROGRAM.
 ``

    (a) In General.--The Secretary shall establish or continue 
activities to support a comprehensive fetal alcohol spectrum disorders 
(referred to in this section as `FASD') education, prevention, 
identification, intervention, and services delivery program, which may 
include--
 ``

    (1) an education and public awareness program to support, 
 conduct, and evaluate the effectiveness of--
 ``
        (A) educational programs targeting health professions 
 schools, social and other supportive services, educators and 
 counselors and other service providers in all phases of 
 childhood development, and other relevant service providers, 
 concerning the prevention, identification, and provision of 
 services for infants, children, adolescents, and adults with 
 FASD;
 ``
        (B) strategies to educate school-age children, including 
 pregnant and high-risk youth, concerning FASD;
 ``
            (C) public and community awareness programs concerning 
 FASD; and
 ``
            (D) strategies to coordinate information and services 
 across affected community agencies, including agencies 
 providing social services such as foster care, adoption, and 
 social work, agencies providing health services, and agencies 
 involved in education, vocational training, and civil and 
 criminal justice;
 ``

    (2) supporting and conducting research on FASD, as 
 appropriate, including to--
 ``
        (A) develop appropriate medical diagnostic methods for 
 identifying FASD; and
 ``
        (B) develop effective culturally and linguistically 
 appropriate evidence-based or evidence-informed interventions 
 and appropriate supports for preventing prenatal alcohol 
 exposure, which may co-occur with exposure to other substances;
 ``

    (3) building State and Tribal capacity for the 
 identification, treatment, and support of individuals with FASD and 
 their families, which may include--
 ``
        (A) utilizing and adapting existing Federal, State, or 
 Tribal programs to include FASD identification and FASD-
 informed support;
 ``
        (B) developing and expanding screening and diagnostic 
 capacity for FASD;
 ``
            (C) developing, implementing, and evaluating targeted 
 FASD-informed intervention programs for FASD;
 ``
            (D) providing training with respect to FASD for 
 professionals across relevant sectors; and
 ``
        (E) disseminating information about FASD and support 
 services to affected individuals and their families; and
 ``

    (4) an applied research program concerning intervention and 
 prevention to support and conduct service demonstration projects, 
 clinical studies and other research models providing advocacy, 
 educational and vocational training, counseling, medical and mental 
 health, and other supportive services, as well as models that 
 integrate and coordinate such services, that are aimed at the 
 unique challenges facing individuals with fetal alcohol spectrum 
 disorder or fetal alcohol effect and their families.
 ``

    (b) Grants and Technical Assistance.--
 ``

    (1) In general.--The Secretary may award grants, cooperative 
 agreements and contracts and provide technical assistance to 
 eligible entities to carry out subsection

    (a) .
 ``

    (2) Eligible entities.--To be eligible to receive a grant, or 
 enter into a cooperative agreement or contract, under this section, 
 an entity shall--
 ``
        (A) be a State, Indian Tribe or Tribal organization, 
 local government, scientific or academic institution, or 
 nonprofit organization; and
 ``
        (B) prepare and submit to the Secretary an application at 
 such time, in such manner, and containing such information as 
 the Secretary may require, including a description of the 
 activities that the entity intends to carry out using amounts 
 received under this section.
 ``

    (3) Additional application contents.--The Secretary may 
 require that an eligible entity include in the application 
 submitted under paragraph

    (2)
        (B) --
 ``
        (A) a designation of an individual to serve as a FASD 
 State or Tribal coordinator of activities such eligible entity 
 proposes to carry out through a grant, cooperative agreement, 
 or contract under this section; and
 ``
        (B) a description of an advisory committee the entity 
 will establish to provide guidance for the entity on developing 
 and implementing a statewide or Tribal strategic plan to 
 prevent FASD and provide for the identification, treatment, and 
 support of individuals with FASD and their families.
 ``
            (c) Definition of FASD-Informed.--For purposes of this section, 
the term `FASD-informed', with respect to support or an intervention 
program, means that such support or intervention program uses 
culturally and linguistically informed evidence-based or practice-based 
interventions and appropriate resources to support an improved quality 
of life for an individual with FASD and the family of such individual.
``

SEC. 399I. STRENGTHENING CAPACITY AND EDUCATION FOR FETAL ALCOHOL 
SPECTRUM DISORDERS.
 ``

    (a) In General.--The Secretary shall award grants, contracts, or 
cooperative agreements, as the Secretary determines appropriate, to 
public or nonprofit private entities with demonstrated expertise in the 
field of fetal alcohol spectrum disorders (referred to in this section 
as `FASD'). Such awards shall be for the purposes of building local, 
Tribal, State, and nationwide capacities to prevent the occurrence of 
FASD by carrying out the programs described in subsection

    (b) .
 ``

    (b) Programs.--An entity receiving an award under subsection

    (a) may use such award for the following purposes:
 ``

    (1) Developing and supporting public education and outreach 
 activities to raise public awareness of the risks associated with 
 alcohol consumption during pregnancy.
 ``

    (2) Acting as a clearinghouse for evidence-based resources on 
 FASD prevention, identification, and culturally and linguistically 
 appropriate best practices to help inform systems of care for 
 individuals with FASD across their lifespan.
 ``

    (3) Increasing awareness and understanding of efficacious, 
 evidence-based screening tools and culturally and linguistically 
 appropriate evidence-based intervention services and best 
 practices, which may include improving the capacity for State, 
 Tribal, and local affiliates.
 ``

    (4) Providing technical assistance to recipients of grants, 
 cooperative agreements, or contracts under 

section 399H, as 
 appropriate.
 ``
            (c) Application.--To be eligible for a grant, contract, or 
cooperative agreement under this section, an entity shall submit to the 
Secretary an application at such time, in such manner, and containing 
such information as the Secretary may require.
 ``
            (d) Subcontracting.--A public or private nonprofit entity may 
carry out the following activities required under this section through 
contracts or cooperative agreements with other public and private 
nonprofit entities with demonstrated expertise in FASD:
 ``

    (1) Resource development and dissemination.
 ``

    (2) Intervention services.
 ``

    (3) Training and technical assistance.
``

SEC. 399J. AUTHORIZATION OF APPROPRIATIONS.
 ``There are authorized to be appropriated to carry out this part 
$12,500,000 for each of fiscal years 2026 through 2030.''.

    (b) Report.--Not later than 4 years after the date of enactment of 
this Act, and every year thereafter, the Secretary of Health and Human 
Services shall prepare and submit to the Committee on Health, 
Education, Labor, and Pensions of the Senate and the Committee on 
Energy and Commerce of the House of Representatives a report 
containing--

    (1) a review of the activities carried out pursuant to sections 
 399H and 399I of the Public Health Service Act, as amended, to 
 advance public education and awareness of fetal alcohol spectrum 
 disorders (referred to in this section as ``FASD'');

    (2) a description of--
        (A) the activities carried out pursuant to such sections 
 399H and 399I to identify, prevent, and treat FASD; and
        (B) methods used to evaluate the outcomes of such 
 activities; and

    (3) an assessment of activities carried out pursuant to such 
 sections 399H and 399I to support individuals with FASD.
 

SEC. 105. PROMOTING STATE CHOICE IN PDMP SYSTEMS.
 

Section 399O

    (h) of the Public Health Service Act (42 U.S.C. 280g-
3

    (h) ) is amended by adding at the end the following:
 ``

    (5) Promoting state choice.--Nothing in this section shall be 
 construed to authorize the Secretary to require States to use a 
 specific vendor or a specific interoperability connection other 
 than to align with nationally recognized, consensus-based open 
 standards, such as in accordance with sections 3001 and 3004.''.
 

SEC. 106. FIRST RESPONDER TRAINING PROGRAM.
 

Section 546 of the Public Health Service Act (42 U.S.C. 290ee-1) is 
amended--

    (1) in subsection

    (a) , by striking ``tribes and tribal'' and 
 inserting ``Tribes and Tribal'';

    (2) in subsections

    (a) ,
            (c) , and
            (d) --
        (A) by striking ``approved or cleared'' each place it 
 appears and inserting ``approved, cleared, or otherwise legally 
 marketed''; and
        (B) by striking ``opioid'' each place it appears;

    (3) in subsection

    (f) --
        (A) by striking ``approved or cleared'' each place it 
 appears and inserting ``approved, cleared, or otherwise legally 
 marketed'';
        (B) in paragraph

    (1) , by striking ``opioid'';
            (C) in paragraph

    (2) --
            (i) by striking ``opioid and heroin'' and inserting 
 ``opioid, heroin, and other drug''; and
            (ii) by striking ``opioid overdose'' and inserting 
 ``overdose''; and
            (D) in paragraph

    (3) , by striking ``opioid and heroin''; 
 and

    (4) in subsection

    (h) , by striking ``$36,000,000 for each of 
 fiscal years 2019 through 2023'' and inserting ``$57,000,000 for 
 each of fiscal years 2026 through 2030''.
 

SEC. 107. DONALD J. COHEN NATIONAL CHILD TRAUMATIC STRESS 
 INITIATIVE.

    (a) Technical Amendment.--The second part G of title V of the 
Public Health Service Act (42 U.S.C. 290kk et seq.), as added by 

section 144 of the Community Renewal Tax Relief Act of 2000 (Public Law 
106-554), is amended--

    (1) by redesignating such part as part J; and

    (2) by redesignating sections 581 through 584 as sections 596 
 through 596C, respectively.

    (b) In General.--

Section 582 of the Public Health Service Act (42 
U.S.C. 290hh-1) is amended--

    (1) in the section heading, by striking ``violence related 
 stress'' and inserting ``traumatic events'';

    (2) in subsection

    (a) --
        (A) in the matter preceding paragraph

    (1) , by striking 
 ``tribes and tribal'' and inserting ``Tribes and Tribal''; and
        (B) in paragraph

    (2) , by inserting ``and dissemination'' 
 after ``the development'';

    (3) in subsection

    (b) , by inserting ``and dissemination'' after 
 ``the development'';

    (4) in subsection
            (d) --
        (A) by striking ``The NCTSI'' and inserting the following:
 ``

    (1) Coordinating center.--The NCTSI''; and
        (B) by adding at the end the following:
 ``

    (2) NCTSI grantees.--In carrying out subsection

    (a)

    (2) , NCTSI 
 grantees shall develop trainings and other resources, as applicable 
 and appropriate, to support implementation of the evidence-based 
 practices developed and disseminated under such subsection.'';

    (5) in subsection

    (e) --
        (A) by redesignating paragraphs

    (1) and

    (2) as 
 subparagraphs
        (A) and
        (B) , respectively, and adjusting the 
 margins accordingly;
        (B) in subparagraph
        (A) , as so redesignated, by inserting 
 ``and implementation'' after ``the dissemination'';
            (C) by striking ``The NCTSI'' and inserting the following:
 ``

    (1) Coordinating center.--The NCTSI''; and
            (D) by adding at the end the following:
 ``

    (2) NCTSI grantees.--NCTSI grantees shall, as appropriate, 
 collaborate with other such grantees, the NCTSI coordinating 
 center, and the Secretary in carrying out subsections

    (a)

    (2) and
            (d) (2) .'';

    (6) by amending subsection

    (h) to read as follows:
 ``

    (h) Application and Evaluation.--To be eligible to receive a 
grant, contract, or cooperative agreement under subsection

    (a) , a 
public or nonprofit private entity or an Indian Tribe or Tribal 
organization shall submit to the Secretary an application at such time, 
in such manner, and containing such information and assurances as the 
Secretary may require, including--
 ``

    (1) a plan for the evaluation of the activities funded under 
 the grant, contract, or agreement, including both process and 
 outcomes evaluation, and the submission of an evaluation at the end 
 of the project period; and
 ``

    (2) a description of how such entity, Indian Tribe, or Tribal 
 organization will support efforts led by the Secretary or the NCTSI 
 coordinating center, as applicable, to evaluate activities carried 
 out under this section.''; and

    (7) by amending subsection

    (j) to read as follows:
 ``

    (j) Authorization of Appropriations.--There is authorized to be 
appropriated to carry out this section--
 ``

    (1) $98,887,000 for fiscal year 2026;
 ``

    (2) $98,887,000 for fiscal year 2027;
 ``

    (3) $98,887,000 for fiscal year 2028;
 ``

    (4) $100,000,000 for fiscal year 2029; and
 ``

    (5) $100,000,000 for fiscal year 2030.''.
 

SEC. 108. PROTECTING SUICIDE PREVENTION LIFELINE FROM CYBERSECURITY 
 INCIDENTS.

    (a) National Suicide Prevention Lifeline Program.--

Section 520E-
3

    (b) of the Public Health Service Act (42 U.S.C. 290bb-36c

    (b) ) is 
amended--

    (1) in paragraph

    (4) , by striking ``and'' at the end;

    (2) in paragraph

    (5) , by striking the period at the end and 
 inserting ``; and''; and

    (3) by adding at the end the following:
 ``

    (6) taking such steps as may be necessary to ensure the 
 suicide prevention hotline is protected from cybersecurity 
 incidents and eliminates known cybersecurity vulnerabilities.''.

    (b) Reporting.--

Section 520E-3 of the Public Health Service Act (42 
U.S.C. 290bb-36c) is amended--

    (1) by redesignating subsection

    (f) as subsection

    (g) ; and

    (2) by inserting after subsection

    (e) the following:
 ``

    (f) Cybersecurity Reporting.--
 ``

    (1) Notification.--
 ``
        (A) In general.--The program's network administrator 
 receiving Federal funding pursuant to subsection

    (a) shall 
 report to the Assistant Secretary, in a manner that protects 
 personal privacy, consistent with applicable Federal and State 
 privacy laws--
 ``
            (i) any identified cybersecurity vulnerabilities to 
 the program within a reasonable amount of time after 
 identification of such a vulnerability; and
 ``
            (ii) any identified cybersecurity incidents to the 
 program within a reasonable amount of time after 
 identification of such incident.
 ``
        (B) Local and regional crisis centers.--Local and 
 regional crisis centers participating in the program shall 
 report to the program's network administrator identified under 
 subparagraph
        (A) , in a manner that protects personal privacy, 
 consistent with applicable Federal and State privacy laws--
 ``
            (i) any identified cybersecurity vulnerabilities to 
 the program within a reasonable amount of time after 
 identification of such vulnerability; and
 ``
            (ii) any identified cybersecurity incidents to the 
 program within a reasonable amount of time after 
 identification of such incident.
 ``

    (2) Notification.--If the program's network administrator 
 receiving funding pursuant to subsection

    (a) discovers, or is 
 informed by a local or regional crisis center pursuant to paragraph

    (1)
        (B) of, a cybersecurity vulnerability or incident, within a 
 reasonable amount of time after such discovery or receipt of 
 information, such entity shall report the vulnerability or incident 
 to the Assistant Secretary.
 ``

    (3) Clarification.--
 ``
        (A) Oversight.--
 ``
            (i) Local and regional crisis centers.--Except as 
 provided in clause
            (ii) , local and regional crisis centers 
 participating in the program shall oversee all technology 
 each center employs in the provision of services as a 
 participant in the program.
 ``
            (ii) Network administrator.--The program's network 
 administrator receiving Federal funding pursuant to 
 subsection

    (a) shall oversee the technology each crisis 
 center employs in the provision of services as a 
 participant in the program if such oversight 
 responsibilities are established in the applicable network 
 participation agreement.
 ``
        (B) Supplement, not supplant.--The cybersecurity incident 
 reporting requirements under this subsection shall supplement, 
 and not supplant, cybersecurity incident reporting requirements 
 under other provisions of applicable Federal law that are in 
 effect on the date of the enactment of the SUPPORT for Patients 
 and Communities Reauthorization Act of 2025.''.
            (c) Study.--Not later than 180 days after the date of the enactment 
of this Act, the Comptroller General of the United States shall--

    (1) conduct and complete a study that evaluates cybersecurity 
 risks and vulnerabilities associated with the 9-8-8 National 
 Suicide Prevention Lifeline; and

    (2) submit a report on the findings of such study to the 
 Committee on Health, Education, Labor, and Pensions of the Senate 
 and the Committee on Energy and Commerce of the House of 
 Representatives.
 

SEC. 109. MONITORING AND REPORTING OF CHILD, YOUTH, AND ADULT 
 TRAUMA.
 

Section 7131

    (e) of the SUPPORT for Patients and Communities Act (42 
U.S.C. 242t

    (e) ) is amended by striking ``$2,000,000 for each of fiscal 
years 2019 through 2023'' and inserting ``$9,000,000 for each of fiscal 
years 2026 through 2030''.
 

SEC. 110. BRUCE'S LAW.

    (a) Youth Prevention and Recovery.--

Section 7102
            (c) of the SUPPORT 
for Patients and Communities Act (42 U.S.C. 290bb-7a
            (c) ) is amended--

    (1) in paragraph

    (3)
        (A)
            (i) , by inserting ``, which may include 
 strategies to increase education and awareness of the potency and 
 dangers of synthetic opioids (including drugs contaminated with 
 fentanyl) and, as appropriate, other emerging drug use or misuse 
 issues'' before the semicolon; and

    (2) in paragraph

    (4)
        (A) , by inserting ``and strategies to 
 increase education and awareness of the potency and dangers of 
 synthetic opioids (including drugs contaminated with fentanyl) and, 
 as appropriate, emerging drug use or misuse issues'' before the 
 semicolon.

    (b) Interdepartmental Substance Use Disorders Coordinating 
Committee.--

Section 7022 of the SUPPORT for Patients and Communities 
Act (42 U.S.C. 290aa note) is amended--

    (1) by striking subsection

    (g) and inserting the following:
 ``

    (g) Working Groups.--
 ``

    (1) In general.--The Committee may establish working groups 
 for purposes of carrying out the duties described in subsection

    (e) . Any such working group shall be composed of members of the 
 Committee (or the designees of such members) and may hold such 
 meetings as are necessary to carry out the duties delegated to the 
 working group.
 ``

    (2) Additional federal interagency work group on fentanyl 
 contamination of illegal drugs.--
 ``
        (A) Establishment.--The Secretary, acting through the 
 Committee, shall establish a Federal Interagency Work Group on 
 Fentanyl Contamination of Illegal Drugs (referred to in this 
 paragraph as the `Work Group') consisting of representatives 
 from relevant Federal departments and agencies on the 
 Committee.
 ``
        (B) Consultation.--The Work Group shall consult with 
 relevant stakeholders and subject matter experts, including--
 ``
            (i) State, Tribal, and local subject matter experts 
 in reducing, preventing, and responding to drug overdose 
 caused by fentanyl contamination of illicit drugs; and
 ``
            (ii) family members of both adults and youth who have 
 overdosed by fentanyl contaminated illicit drugs.
 ``
            (C) Duties.--The Work Group shall--
 ``
            (i) examine Federal efforts to reduce and prevent 
 drug overdose by fentanyl-contaminated illicit drugs;
 ``
            (ii) identify strategies to improve State, Tribal, 
 and local responses to overdose by fentanyl-contaminated 
 illicit drugs;
 ``
            (iii) coordinate with the Secretary, as appropriate, 
 in carrying out activities to raise public awareness of 
 synthetic opioids and other emerging drug use and misuse 
 issues;
 ``
            (iv) make recommendations to Congress for improving 
 Federal programs, including with respect to the 
 coordination of efforts across such programs; and
 ``
            (v) make recommendations for educating youth on the 
 potency and dangers of drugs contaminated by fentanyl.
 ``
            (D) Annual report to secretary.--The Work Group shall 
 annually prepare and submit to the Secretary, the Committee on 
 Health, Education, Labor, and Pensions of the Senate, and the 
 Committee on Energy and Commerce and the Committee on Education 
 and Workforce of the House of Representatives, a report on the 
 activities carried out by the Work Group under subparagraph
            (C) , including recommendations to reduce and prevent drug 
 overdose by fentanyl contamination of illegal drugs, in all 
 populations, and specifically among youth at risk for substance 
 misuse.''; and

    (2) by striking subsection
            (i) and inserting the following:
 ``
            (i) Sunset.--The Committee shall terminate on September 30, 
2030.''.
 

SEC. 111. GUIDANCE ON AT-HOME DRUG DISPOSAL SYSTEMS.

    (a) In General.--Not later than one year after the date of 
enactment of this Act, the Secretary of Health and Human Services, in 
consultation with the Administrator of the Drug Enforcement 
Administration, shall publish guidance to facilitate the use of at-home 
safe disposal systems for applicable drugs.

    (b) Contents.--The guidance under subsection

    (a) shall include--

    (1) recommended standards for effective at-home drug disposal 
 systems to meet applicable requirements enforced by the Food and 
 Drug Administration;

    (2) recommended information to include as instructions for use 
 to disseminate with at-home drug disposal systems;

    (3) best practices and educational tools to support the use of 
 an at-home drug disposal system, as appropriate; and

    (4) recommended use of licensed health providers for the 
 dissemination of education, instruction, and at-home drug disposal 
 systems, as appropriate.
 

SEC. 112. ASSESSMENT OF OPIOID DRUGS AND ACTIONS.

    (a) In General.--Not later than one year after the date of 
enactment of this Act, the Secretary of Health and Human Services 
(referred to in this section as the ``Secretary'') shall publish on the 
website of the Food and Drug Administration (referred to in this 
section as the ``FDA'') a report that outlines a plan for assessing 
opioid analgesic drugs that are approved under 

section 505 of the 
Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355) that addresses the 
public health effects of such opioid analgesic drugs as part of the 
benefit-risk assessment and the activities of the FDA that relate to 
facilitating the development of nonaddictive medical products intended 
to treat pain or addiction. Such report shall include--

    (1) an update on the actions taken by the FDA to consider the 
 effectiveness, safety, benefit-risk profile, and use of approved 
 opioid analgesic drugs;

    (2) a timeline for an assessment of the potential need, as 
 appropriate, for labeling changes, revised or additional 
 postmarketing requirements, enforcement actions, or withdrawals for 
 opioid analgesic drugs;

    (3) an overview of the steps that the FDA has taken to support 
 the development and approval of nonaddictive medical products 
 intended to treat pain or addiction, and actions planned to further 
 support the development and approval of such products; and

    (4) an overview of the consideration by the FDA of clinical 
 trial methodologies for analgesic drugs, including the enriched 
 enrollment randomized withdrawal methodology, and the benefits and 
 drawbacks associated with different trial methodologies for such 
 drugs, incorporating any public input received under subsection

    (b) .

    (b) Public Input.--In carrying out subsection

    (a) , the Secretary 
shall provide an opportunity for public input concerning the regulation 
by the FDA of opioid analgesic drugs, including scientific evidence 
that relates to conditions of use, safety, or benefit-risk assessment 
(including consideration of the public health effects) of such opioid 
analgesic drugs.
 

SEC. 113. GRANT PROGRAM FOR STATE AND TRIBAL RESPONSE TO OPIOID USE 
 DISORDERS.
 The activities carried out pursuant to 

section 1003

    (b)

    (4)
        (A) of the 
21st Century Cures Act (42 U.S.C. 290ee-3a

    (b)

    (4)
        (A) ) may include 
facilitating access to products used to prevent overdose deaths by 
detecting the presence of one or more substances, such as fentanyl and 
xylazine test strips, to the extent the purchase and possession of such 
products is consistent with Federal and State law.

 TITLE II--TREATMENT

 

SEC. 201. RESIDENTIAL TREATMENT PROGRAM FOR PREGNANT AND POSTPARTUM 
 WOMEN.
 

Section 508 of the Public Health Service Act (42 U.S.C. 290bb-1) is 
amended--

    (1) in subsection
            (d) (11)
            (C) , by striking ``providing health 
 services'' and inserting ``providing health care services'';

    (2) in subsection

    (g) --
        (A) by inserting ``a plan describing'' after ``will 
 provide''; and
        (B) by adding at the end the following: ``Such plan may 
 include a description of how such applicant will target 
 outreach to women disproportionately impacted by maternal 
 substance use disorder.''; and

    (3) in subsection

    (s) , by striking ``$29,931,000 for each of 
 fiscal years 2019 through 2023'' and inserting ``$38,931,000 for 
 each of fiscal years 2026 through 2030''.
 

SEC. 202. IMPROVING ACCESS TO ADDICTION MEDICINE PROVIDERS.
 

Section 597 of the Public Health Service Act (42 U.S.C. 290ll) is 
amended--

    (1) in subsection

    (a)

    (1) , by inserting ``diagnosis,'' after 
 ``related to''; and

    (2) in subsection

    (b) , by inserting ``addiction medicine,'' 
 after ``psychiatry,''.
 

SEC. 203. MENTAL AND BEHAVIORAL HEALTH EDUCATION AND TRAINING 
 GRANTS.
 

Section 756

    (f) of the Public Health Service Act (42 U.S.C. 294e-
1

    (f) ) is amended by striking ``fiscal years 2023 through 2027'' and 
inserting ``fiscal years 2026 through 2030''.
 

SEC. 204. LOAN REPAYMENT PROGRAM FOR SUBSTANCE USE DISORDER 
 TREATMENT WORKFORCE.
 

Section 781

    (j) of the Public Health Service Act (42 U.S.C. 295h

    (j) ) 
is amended by striking ``$25,000,000 for each of fiscal years 2019 
through 2023'' and inserting ``$40,000,000 for each of fiscal years 
2026 through 2030''.
 

SEC. 205. DEVELOPMENT AND DISSEMINATION OF MODEL TRAINING PROGRAMS 
 FOR SUBSTANCE USE DISORDER PATIENT RECORDS.
 

Section 7053 of the SUPPORT for Patients and Communities Act (42 
U.S.C. 290dd-2 note) is amended by striking subsection

    (e) .
 

SEC. 206. TASK FORCE ON BEST PRACTICES FOR TRAUMA-INFORMED 
 IDENTIFICATION, REFERRAL, AND SUPPORT.
 

Section 7132 of the SUPPORT for Patients and Communities Act 
(Public Law 115-271; 132 Stat. 4046) is amended--

    (1) in subsection

    (b)

    (1) --
        (A) by redesignating subparagraph
            (CC) as subparagraph
            (DD) ; and
        (B) by inserting after subparagraph

    (BB) the following:
 ``
            (CC) The Administration for Community Living.'';

    (2) in subsection
            (d) (1) , in the matter preceding subparagraph
        (A) , by inserting ``, developmental disability service providers'' 
 before ``, individuals who are''; and

    (3) in subsection
            (i) , by striking ``2023'' and inserting 
 ``2030''.
 

SEC. 207. GRANTS TO ENHANCE ACCESS TO SUBSTANCE USE DISORDER 
 TREATMENT.
 

Section 3203 of the SUPPORT for Patients and Communities Act (21 
U.S.C. 823 note) is amended--

    (1) by striking subsection

    (b) ; and

    (2) by striking ``

    (a) In General.--The Secretary'' and 
 inserting the following: ``The Secretary''.
 

SEC. 208. STATE GUIDANCE RELATED TO INDIVIDUALS WITH SERIOUS MENTAL 
 ILLNESS AND CHILDREN WITH SERIOUS EMOTIONAL DISTURBANCE.

    (a) Review of Use of Certain Funding.--Not later than 1 year after 
the date of enactment of this Act, the Secretary of Health and Human 
Services (referred to in this section as the ``Secretary''), acting 
through the Assistant Secretary for Mental Health and Substance Use, 
shall conduct a review of State use of funds made available under the 
Community Mental Health Services Block Grant program under subpart I of 
part B of title XIX of the Public Health Service Act (42 U.S.C. 300x et 
seq.) (referred to in this section as the ``block grant program'') for 
first episode psychosis activities. Such review shall consider the 
following:

    (1) How States use funds for evidence-based treatments and 
 services according to the standard of care for individuals with 
 early serious mental illness and children with a serious emotional 
 disturbance.

    (2) The percentages of the State funding under the block grant 
 program expended on early serious mental illness and first episode 
 psychosis, and the number of individuals served under such funds.

    (b) Report and Guidance.--

    (1) Report.--Not later than 180 days after the completion of 
 the review under subsection

    (a) , the Secretary shall submit to the 
 Committee on Health, Education, Labor, and Pensions and the 
 Committee on Appropriations of the Senate and the Committee on 
 Energy and Commerce and the Committee on Appropriations of the 
 House of Representatives a report describing--
        (A) the findings of the review under subsection

    (a) ; and
        (B) any recommendations for changes to the block grant 
 program that would facilitate improved outcomes for individuals 
 with serious mental illness and children with serious emotional 
 disturbance.

    (2) Guidance.--Not later than 1 year after the date on which 
 the report is submitted under paragraph

    (1) , the Secretary shall 
 update the guidance provided to States under the block grant 
 program on coordinated specialty care and other evidence-based 
 mental health care services for individuals with serious mental 
 illness and children with a serious emotional disturbance, based on 
 the findings and recommendations of such report.
 

SEC. 209. REVIEWING THE SCHEDULING OF APPROVED PRODUCTS CONTAINING 
 A COMBINATION OF BUPRENORPHINE AND NALOXONE.

    (a) Secretary of HHS.--The Secretary of Health and Human Services 
shall, consistent with the requirements and procedures set forth in 
sections 201 and 202 of the Controlled Substances Act (21 U.S.C. 811, 
812)--

    (1) review the relevant data pertaining to the scheduling of 
 products containing a combination of buprenorphine and naloxone 
 that have been approved under 

section 505 of the Federal Food, 
 Drug, and Cosmetic Act (21 U.S.C. 355); and

    (2) if appropriate, request that the Attorney General initiate 
 rulemaking proceedings to revise the schedules accordingly with 
 respect to such products.

    (b) Attorney General.--The Attorney General shall review any 
request made by the Secretary of Health and Human Services under 
subsection

    (a)

    (2) and determine whether to initiate proceedings to 
revise the schedules in accordance with the criteria set forth in 
sections 201 and 202 of the Controlled Substances Act (21 U.S.C. 811, 
812).
 

SEC. 210. REFERENCES TO OPIOID OVERDOSE REVERSAL AGENTS IN HHS 
 GRANT PROGRAMS.

    (a) In General.--The Secretary of Health and Human Services shall 
ensure that, as appropriate, whenever the Department of Health and 
Human Services issues a regulation or guidance for any grant program 
addressing opioid misuse and use disorders, any reference to an opioid 
overdose reversal drug (such as a reference to naloxone) is inclusive 
of any opioid overdose reversal drug that has been approved under 

section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355) 
for emergency treatment of a known or suspected opioid overdose.

    (b) Existing References.--

    (1) Update.--Not later than one year after the date of 
 enactment of this Act, the Secretary of Health and Human Services 
 shall update all references described in paragraph

    (2) to be 
 inclusive of any opioid overdose reversal drug that has been 
 approved or otherwise authorized for use by the Food and Drug 
 Administration.

    (2) References.--A reference described in this paragraph is any 
 reference to an opioid overdose reversal drug (such as naloxone) in 
 any regulation or guidance of the Department of Health and Human 
 Services that--
        (A) was issued before the date of enactment of this Act; 
 and
        (B) is included in--
            (i) the grant program for State and Tribal response to 
 opioid use disorders under 

section 1003 of the 21st Century 
 Cures Act (42 U.S.C. 290ee-3 note) (commonly referred to as 
 ``State Opioid Response Grants'' and ``Tribal Opioid 
 Response Grants''); or
            (ii) the grant program for priority substance use 
 disorder prevention needs of regional and national 
 significance under 

section 516 of the Public Health Service 
 Act (42 U.S.C. 290bb-22).
 

SEC. 211. ROUNDTABLE ON USING HEALTH INFORMATION TECHNOLOGY TO 
 IMPROVE MENTAL HEALTH AND SUBSTANCE USE CARE OUTCOMES.

    (a) Roundtable.--Not later than 180 days after the date of 
enactment of this Act, the National Coordinator for Health Information 
Technology shall convene a public roundtable to examine--

    (1) how the expanded use of electronic health records among 
 mental health and substance use service providers can improve 
 outcomes for patients in mental health and substance use settings; 
 and

    (2) how best to increase electronic health record adoption 
 among such providers.

    (b) Participants.--The National Coordinator for Health Information 
Technology shall ensure that the participants in the roundtable under 
subsection

    (a) include private and public sector stakeholders, 
including patients, providers (including providers of inpatient 
services and providers of outpatient services), and representatives of 
payors, health information exchanges, professional associations, health 
information technology vendors, health information technology 
certification organizations, and State and Federal agencies.
            (c) Report.--Not later than 180 days after the conclusion of the 
public stakeholder roundtable under subsection

    (a) , the National 
Coordinator for Health Information Technology shall submit to the 
Committee on Health, Education, Labor, and Pensions of the Senate and 
the Committee on Energy and Commerce of the House of Representatives a 
report outlining information gathered from the roundtable under 
subsection

    (a) . Such report shall include an examination of--

    (1) recommendations from the roundtable participants;

    (2) unique considerations for using electronic health record 
 systems in mental health and substance use treatment settings;

    (3) unique considerations for developers of health information 
 technology relating to certification of electronic health record 
 systems for use in mental health and substance use treatment 
 settings where the applicable health information technology is not 
 subject to certification requirements;

    (4) current usage of electronic health record systems by mental 
 health and substance use disorder service providers, and the scope 
 and magnitude of such providers that do not use electronic health 
 record systems;

    (5) examples of how electronic health record systems enable 
 coordinated care and care management;

    (6) how electronic health record systems advance appropriate 
 patient and provider access to secure, usable electronic 
 information exchange;

    (7) how electronic health record systems can be connected to or 
 support existing systems, which may include the 9-8-8 National 
 Suicide Prevention Lifeline, mobile crisis response systems, and 
 co-responder programs, to facilitate connectivity, response, and 
 integrated care;

    (8) any existing programs to support greater adoption of 
 electronic health record systems among mental health and substance 
 use service providers;

    (9) any limitations to greater adoption of electronic health 
 record systems among mental health and substance use service 
 providers;

    (10) the costs of adoption of electronic health record systems 
 by mental health and substance use disorder service providers; and

    (11) best practices implemented by States and other entities to 
 support adoption of use of electronic health records among mental 
 health and substance use disorder service providers.

 TITLE III--RECOVERY

 

SEC. 301. BUILDING COMMUNITIES OF RECOVERY.
 

Section 547

    (f) of the Public Health Service Act (42 U.S.C. 290ee-
2

    (f) ) is amended by striking ``$5,000,000 for each of fiscal years 2019 
through 2023'' and inserting ``$17,000,000 for each of fiscal years 
2026 through 2030''.
 

SEC. 302. PEER SUPPORT TECHNICAL ASSISTANCE CENTER.
 

Section 547A of the Public Health Service Act (42 U.S.C. 290ee-2a) 
is amended--

    (1) in subsection

    (b)

    (4) , by striking ``building; and'' and 
 inserting the following: ``building, such as--
 ``
        (A) professional development of peer support specialists; 
 and
 ``
        (B) making recovery support services available in 
 nonclinical settings; and'';

    (2) by redesignating subsections
            (d) and

    (e) as subsections

    (e) and

    (f) , respectively;

    (3) by inserting after subsection
            (c) the following:
 ``
            (d) Regional Centers.--
 ``

    (1) In general.--The Secretary may establish one regional 
 technical assistance center (referred to in this subsection as the 
 `Regional Center'), with existing resources, to assist the Center 
 in carrying out activities described in subsection

    (b) within the 
 geographic region of such Regional Center in a manner that is 
 tailored to the needs of such region.
 ``

    (2) Evaluation.--Not later than 4 years after the date of 
 enactment of the SUPPORT for Patients and Communities 
 Reauthorization Act of 2025, the Secretary shall evaluate the 
 activities of the Regional Center and submit to the Committee on 
 Health, Education, Labor, and Pensions of the Senate and the 
 Committee on Energy and Commerce of the House of Representatives a 
 report on the findings of such evaluation, including--
 ``
        (A) a description of the distinct roles and 
 responsibilities of the Regional Center and the Center;
 ``
        (B) available information relating to the outcomes of the 
 Regional Center under this subsection, such as any impact on 
 the operations and efficiency of the Center relating to 
 requests for technical assistance and support within the region 
 of such Regional Center;
 ``
            (C) a description of any gaps or areas of duplication 
 relating to the activities of the Regional Center and the 
 Center within such region; and
 ``
            (D) recommendations relating to the modification, 
 expansion, or termination of the Regional Center under this 
 subsection.
 ``

    (3) Termination.--This subsection shall terminate on 
 September 30, 2030.''; and

    (4) in subsection

    (f) , as so redesignated, by striking 
 ``$1,000,000 for each of fiscal years 2019 through 2023'' and 
 inserting ``$2,000,000 for each of fiscal years 2026 through 
 2030''.
 

SEC. 303. COMPREHENSIVE OPIOID RECOVERY CENTERS.
 

Section 552 of the Public Health Service Act (42 U.S.C. 290ee-7) is 
amended--

    (1) in subsection
            (d) (2) --
        (A) in the matter preceding subparagraph
        (A) , by striking 
 ``and in such manner'' and inserting ``, in such manner, and 
 containing such information and assurances, including relevant 
 documentation,''; and
        (B) in subparagraph
        (A) , by striking ``is capable of 
 coordinating with other entities to carry out'' and inserting 
 ``has the demonstrated capability to carry out, through 
 referral or contractual arrangements'';

    (2) in subsection

    (h) --
        (A) by redesignating paragraphs

    (1) through

    (4) as 
 subparagraphs
        (A) through
            (D) , respectively, and adjusting the 
 margins accordingly;
        (B) by striking ``With respect to'' and inserting the 
 following:
 ``

    (1) In general.--With respect to''; and
            (C) by adding at the end the following:
 ``

    (2) Additional reporting for certain eligible entities.--An 
 entity carrying out activities described in subsection

    (g) through 
 referral or contractual arrangements shall include in the 
 submissions required under paragraph

    (1) information related to the 
 status of such referrals or contractual arrangements, including an 
 assessment of whether such referrals or contractual arrangements 
 are supporting the ability of such entity to carry out such 
 activities.''; and

    (3) in subsection

    (j) , by striking ``2019 through 2023'' and 
 inserting ``2026 through 2030''.
 

SEC. 304. YOUTH PREVENTION AND RECOVERY.
 

Section 7102
            (c) of the SUPPORT for Patients and Communities Act (42 
U.S.C. 290bb-7a
            (c) ) (as amended by 

section 110

    (a) ) is amended--

    (1) in paragraph

    (2) --
        (A) in subparagraph
        (A) --
            (i) in clause
            (i) --
            (I) by inserting ``, or a consortium of local 
 educational agencies,'' after ``a local educational 
 agency''; and
            (II) by striking ``high schools'' and inserting 
 ``secondary schools''; and
            (ii) in clause
            (vi) , by striking ``tribe, or tribal'' 
 and inserting ``Tribe, or Tribal'';
        (B) by amending subparagraph
        (E) to read as follows:
 ``
        (E) Indian tribe; tribal organization.--The terms `Indian 
 Tribe' and `Tribal organization' have the meanings given such 
 terms in 

section 4 of the Indian Self-Determination and 
 Education Assistance Act (25 U.S.C. 5304).'';
            (C) by redesignating subparagraph
        (K) as subparagraph
            (L) ; 
 and
            (D) by inserting after subparagraph
        (J) the following:
 ``
        (K) Secondary school.--The term `secondary school' has 
 the meaning given such term in 

section 8101 of the Elementary 
 and Secondary Education Act of 1965 (20 U.S.C. 7801).'';

    (2) in paragraph

    (3)
        (A) , in the matter preceding clause
            (i) --
        (A) by striking ``and abuse''; and
        (B) by inserting ``at increased risk for substance misuse'' 
 after ``specific populations'';

    (3) in paragraph

    (4) --
        (A) in the matter preceding subparagraph
        (A) , by striking 
 ``Indian tribes'' and inserting ``Indian Tribes'';
        (B) in subparagraph
        (A) , by striking ``and abuse''; and
            (C) in subparagraph
        (B) , by striking ``peer mentoring'' and 
 inserting ``peer-to-peer support'';

    (4) in paragraph

    (5) , by striking ``tribal'' and inserting 
 ``Tribal'';

    (5) in paragraph

    (6)
        (A) --
        (A) in clause
            (iv) , by striking ``; and'' and inserting a 
 semicolon; and
        (B) by adding at the end the following:
 ``
            (vi) a plan to sustain the activities carried out 
 under the grant program, after the grant program has ended; 
 and'';

    (6) in paragraph

    (8) , by striking ``2022'' and inserting 
 ``2028''; and

    (7) by amending paragraph

    (9) to read as follows:
 ``

    (9) Authorization of appropriations.--To carry out this 
 subsection, there are authorized to be appropriated--
 ``
        (A) $10,000,000 for fiscal year 2026;
 ``
        (B) $12,000,000 for fiscal year 2027;
 ``
            (C) $13,000,000 for fiscal year 2028;
 ``
            (D) $14,000,000 for fiscal year 2029; and
 ``
        (E) $15,000,000 for fiscal year 2030.''.
 

SEC. 305. CAREER ACT.

    (a) In General.--

Section 7183 of the SUPPORT for Patients and 
Communities Act (42 U.S.C. 290ee-8) is amended--

    (1) in the section heading, by inserting ``; treatment, 
 recovery, and workforce support grants'' after ``career act'';

    (2) in subsection

    (b) , by inserting ``each'' before ``for a 
 period'';

    (3) in subsection
            (c) --
        (A) in paragraph

    (1) , by striking ``the rates described in 
 paragraph

    (2) '' and inserting ``the average rates for calendar 
 years 2018 through 2022 described in paragraph

    (2) ''; and
        (B) by amending paragraph

    (2) to read as follows:
 ``

    (2) Rates.--The rates described in this paragraph are the 
 following:
 ``
        (A) The highest age-adjusted average rates of drug 
 overdose deaths for calendar years 2018 through 2022 based on 
 data from the Centers for Disease Control and Prevention, 
 including, if necessary, provisional data for calendar year 
 2022.
 ``
        (B) The highest average rates of unemployment for 
 calendar years 2018 through 2022 based on data provided by the 
 Bureau of Labor Statistics.
 ``
            (C) The lowest average labor force participation rates 
 for calendar years 2018 through 2022 based on data provided by 
 the Bureau of Labor Statistics.'';

    (4) in subsection

    (g) --
        (A) in each of paragraphs

    (1) and

    (3) , by redesignating 
 subparagraphs
        (A) and
        (B) as clauses
            (i) and
            (ii) , 
 respectively, and adjusting the margins accordingly;
        (B) by redesignating paragraphs

    (1) through

    (3) as 
 subparagraphs
        (A) through
            (C) , respectively, and adjusting the 
 margins accordingly;
            (C) in the matter preceding subparagraph
        (A) (as so 
 redesignated), by striking ``An entity'' and inserting the 
 following:
 ``

    (1) In general.--An entity''; and
            (D) by adding at the end the following:
 ``

    (2) Transportation services.--An entity receiving a grant 
 under this section may use not more than 5 percent of the funds for 
 providing transportation for individuals to participate in an 
 activity supported by a grant under this section, which 
 transportation shall be to or from a place of work or a place where 
 the individual is receiving vocational education or job training 
 services or receiving services directly linked to treatment of or 
 recovery from a substance use disorder.
 ``

    (3) Limitation.--The Secretary may not require an entity to, 
 or give priority to an entity that plans to, use the funds of a 
 grant under this section for activities that are not specified in 
 this subsection.'';

    (5) in subsection
            (i) (2) , by inserting ``, which shall include 
 employment and earnings outcomes described in subclauses
            (I) and
            (III) of 

section 116

    (b)

    (2)
        (A)
            (i) of the Workforce Innovation and 
 Opportunity Act (29 U.S.C. 3141

    (b)

    (2)
        (A)
            (i) ) with respect to the 
 participation of such individuals with a substance use disorder in 
 programs and activities funded by the grant under this section'' 
 after ``subsection

    (g) '';

    (6) in subsection

    (j) --
        (A) in paragraph

    (1) , by inserting ``for grants awarded 
 prior to the date of enactment of the SUPPORT for Patients and 
 Communities Reauthorization Act of 2025'' after ``grant period 
 under this section''; and
        (B) in paragraph

    (2) --
            (i) in the matter preceding subparagraph
        (A) , by 
 striking ``2 years after submitting the preliminary report 
 required under paragraph

    (1) '' and inserting ``September 
 30, 2030''; and
            (ii) in subparagraph
        (A) , by striking ``

    (g)

    (3) '' and 
 inserting ``

    (g)

    (1)
            (C) ''; and

    (7) in subsection

    (k) , by striking ``$5,000,000 for each of 
 fiscal years 2019 through 2023'' and inserting ``$12,000,000 for 
 each of fiscal years 2026 through 2030''.

    (b) Reauthorization of the CAREER Act; Recovery Housing Pilot 
Program.--

    (1) In general.--

Section 8071 of the SUPPORT for Patients and 
 Communities Act (42 U.S.C. 5301 note; Public Law 115-271) is 
 amended--
        (A) by striking the section heading and inserting ``career 
 act; recovery housing pilot program'';
        (B) in subsection

    (a) , by striking ``through 2023'' and 
 inserting ``through 2030'';
            (C) in subsection

    (b) --
            (i) in paragraph

    (1) , by striking ``not later than 60 
 days after the date of enactment of this Act'' and 
 inserting ``not later than 60 days after the date of 
 enactment of the SUPPORT for Patients and Communities 
 Reauthorization Act of 2025''; and
            (ii) in paragraph

    (2)
        (B)
            (i) --
            (I) in subclause
            (I) --

    (aa) by striking ``for calendar years 2013 
 through 2017''; and

    (bb) by inserting ``for calendar years 2018 
 through 2022'' after ``rates of unemployment'';
            (II) in subclause
            (II) --

    (aa) by striking ``for calendar years 2013 
 through 2017''; and

    (bb) by inserting ``for calendar years 2018 
 through 2022'' after ``participation rates''; and
            (III) by striking subclause
            (III) and inserting the 
 following:
 ``
            (III) The highest age-adjusted average rates of 
 drug overdose deaths for calendar years 2018 through 
 2022 based on data from the Centers for Disease Control 
 and Prevention, including, if necessary, provisional 
 data for calendar year 2022.''; and
            (D) in subsection

    (f) , by striking ``For the 2-year period 
 following the date of enactment of this Act, the'' and 
 inserting ``The''.

    (2) Conforming amendment.--Subtitle F of title VIII of the 
 SUPPORT for Patients and Communities Act (Public Law 115-271; 132 
 Stat. 4095) is amended by striking the subtitle heading and 
 inserting the following: ``Subtitle F--CAREER Act; Recovery Housing 
 Pilot Program'' .
            (c) Clerical Amendments.--The table of contents in 

section 1

    (b) of 
the SUPPORT for Patients and Communities Act (Public Law 115-271; 132 
Stat. 3894) is amended--

    (1) by striking the item relating to 

section 7183 and inserting 
 the following:
``

Sec. 7183. CAREER Act; treatment, recovery, and workforce support 
 grants.'';

    (2) by striking the item relating to subtitle F of title VIII 
 and inserting the following:

 ``Subtitle F--CAREER Act; Recovery Housing Pilot Program''; and

    (3) by striking the item relating to 

section 8071 and inserting 
 the following:
``

Sec. 8071. CAREER Act; Recovery Housing Pilot Program.''.
 

SEC. 306. ADDRESSING ECONOMIC AND WORKFORCE IMPACTS OF THE OPIOID 
 CRISIS.
 

Section 8041

    (g)

    (1) of the SUPPORT for Patients and Communities Act 
(29 U.S.C. 3225a

    (g)

    (1) ) is amended by striking ``2023'' and inserting 
``2030''.
 

SEC. 307. REVIEW OF INFORMATION RELATED TO FUNDING OPPORTUNITIES 
 UNDER PROGRAMS ADMINISTERED BY SAMHSA.

    (a) In General.--Not later than one year after the date of 
enactment of this Act, the Secretary of Health and Human Services 
(referred to in this section as the ``Secretary'') shall convene a 
public meeting for purposes of improving awareness of, and access to, 
information related to current and future funding opportunities under 
programs administered by the Substance Abuse and Mental Health Services 
Administration (in this section referred to as ``SAMHSA funding 
opportunities'').

    (b) Topics.--The public meeting under subsection

    (a) shall 
include--

    (1) opportunities to improve the utility and functionality of 
 internet websites maintained by the Secretary that provide 
 information related to SAMHSA funding opportunities, such as 
 Grants.gov;

    (2) other models for displaying and disseminating information 
 related to SAMHSA funding opportunities, such as interactive 
 dashboards; and

    (3) strategies to improve the ability of entities to apply for 
 SAMHSA funding opportunities, including entities that have not 
 traditionally applied for SAMHSA funding opportunities.
            (c) Website Improvements.--The Secretary shall implement 
improvements to Grants.gov related to SAMHSA funding opportunities 
based on stakeholder feedback received at the public meeting under 
subsection

    (a) , as appropriate, to the maximum extent feasible.
            (d) Report.--Not later than one year after the date on which the 
public meeting under subsection

    (a) is convened, the Secretary shall 
submit to the Committee on Health, Education, Labor, and Pensions of 
the Senate and the Committee on Energy and Commerce of the House of 
Representatives a report summarizing the findings of such meeting, 
including how the Secretary has taken into account the feedback 
received through such meeting and implemented--

    (1) improvements to internet websites maintained by the 
 Secretary that provide information related to SAMHSA funding 
 opportunities; and

    (2) strategies to improve awareness of SAMHSA funding 
 opportunities.

 TITLE IV--MISCELLANEOUS MATTERS

 

SEC. 401. DELIVERY OF A CONTROLLED SUBSTANCE BY A PHARMACY TO A 
 PRESCRIBING PRACTITIONER.
 

Section 309A

    (a) of the Controlled Substances Act (21 U.S.C. 
829a

    (a) ) is amended by striking paragraph

    (2) and inserting the 
following:
 ``

    (2) the controlled substance is a drug in schedule III, IV, 
 or V to be administered--
 ``
        (A) by injection or implantation for the purpose of 
 maintenance or detoxification treatment; or
 ``
        (B) subject to a risk evaluation and mitigation strategy 
 pursuant to 

section 505-1 of the Federal Food, Drug, and 
 Cosmetic Act (21 U.S.C. 355-1) that includes elements to assure 
 safe use of the drug described in subsection

    (f)

    (3)
        (E) of such 
 section, including a requirement for post-administration 
 monitoring by a health care provider;''.
 

SEC. 402. REQUIRED TRAINING FOR PRESCRIBERS OF CONTROLLED 
 SUBSTANCES.

    (a) In General.--

Section 303 of the Controlled Substances Act (21 
U.S.C. 823) is amended--

    (1) by redesignating the second subsection designated as 
 subsection
            (l) as subsection
            (m) ; and

    (2) in subsection
            (m) (1) , as so redesignated--
        (A) in subparagraph
        (A) --
            (i) in clause
            (iv) --
            (I) in subclause
            (I) --

    (aa) by inserting ``the American Academy of 
 Family Physicians, the American Podiatric Medical 
 Association, the Academy of General Dentistry, the 
 American Optometric Association,'' before ``or any 
 other organization'';

    (bb) by striking ``or the Commission'' and 
 inserting ``, the Commission''; and
            (cc) by inserting ``, or the Council on 
 Podiatric Medical Education'' before the semicolon 
 at the end; and
            (II) in subclause
            (III) , by inserting ``or the 
 American Academy of Family Physicians'' after 
 ``Association''; and
            (ii) in clause
            (v) , in the matter preceding subclause
            (I) --
            (I) by striking ``osteopathic medicine, dental 
 surgery'' and inserting ``osteopathic medicine, 
 podiatric medicine, dental surgery''; and
            (II) by striking ``or dental medicine curriculum'' 
 and inserting ``or dental or podiatric medicine 
 curriculum''; and
        (B) in subparagraph
        (B) --
            (i) in clause
            (i) --
            (I) by inserting ``the American Pharmacists 
 Association, the Accreditation Council on Pharmacy 
 Education, the American Psychiatric Nurses Association, 
 the American Academy of Nursing, the American Academy 
 of Family Physicians,'' before ``or any other 
 organization''; and
            (II) by inserting ``, the American Academy of 
 Family Physicians,'' before ``or the Accreditation 
 Council''; and
            (ii) in clause
            (ii) --
            (I) by striking ``or accredited school'' and 
 inserting ``, an accredited school''; and
            (II) by inserting ``, or an accredited school of 
 pharmacy'' before ``in the United States''.

    (b) Effective Date.--The amendment made by subsection

    (a) shall 
take effect as if enacted on December 29, 2022.

 Speaker of the House of Representatives.

 Vice President of the United States and 
 President of the Senate.